Trends in gene therapy approvals in recent years are rapidly shaping the future ...
XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen...
Starboard has accused Pfizer of “coercive conduct” after executives who initiall...
Booster Therapeutics has announced its inception to develop a new class of prote...
KeyBioscience and Eli Lilly have extended their partnership to develop a new cla...
High-concentration monoclonal antibodies (mAbs) are gaining prominence given the...
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for ...
The Cardiovascular and Renal Drugs Advisory Committee voted 10-6 in support of S...
Plaque psoriasis is a chronic condition that affects millions yet is often misun...
The US FDA approved Itovebi in combination with Pfizer’s Ibrance and AstraZeneca...
City Therapeutics has announced its launch accompanied by a $135m Series A finan...
Ipsen has received the UK MHRA's approval for its Elafibranor (Iqirvo) for the t...
In this issue: The manufacturing shift to meet growing cell and gene therapy dem...
Emergent said it is separately working on increasing the availability of its ove...
As a major report highlights the challenges of a struggling NHS, the call for pr...
